Although current knowledge on circulating VEGF-A levels in COVID-19 vaccine recipients is limited to one study [146], the RS3PE syndrome has been described in two case reports as a consequence of vaccination, suggesting that an increase in this mediator may occur in a proportion of vaccinated individuals [148,149]. The gene discussed is VEGFA; the disease is COVID-19.